Commercial contact between India and Switzerland dates to 1851, when the Volkart Trading Co. established offices in Basel and Mumbai.[1]
Roche was founded in Basel in 1896; it has more than 100,000 people and supplies medicines and diagnostics in over 100 countries.[2]
Basel Area counts more than 33,000 life sciences experts in a region where Switzerland, France and Germany meet.[3]
Indian companies invested US$ 1,277.49 million in Switzerland in 2025-26, led by Dr. Reddy's (US$ 620 million) and Glenmark (US$ 385 million); TCS, Infosys, HCL and Tech Mahindra serve major Swiss pharma companies, banks and insurers.[1]
The Embassy counts over 29,248 Indians in Switzerland, mostly in engineering, IT, pharmaceuticals and nursing, concentrated in Zurich, Geneva, Basel, Baden, Berne and Lausanne, plus 2,419 Indian students.[1]
The second India–Swiss AMR Innovation Dialogue, from 27 April to 2 May 2025, took about 92 experts to universities including Basel's, and to Roche.[1]
The EFTA–India Trade and Economic Partnership Agreement, signed on 10 March 2024, entered into force on 1 October 2025.[4]